Research : Clinical Trials & Studies
Current Clinical Trials
- -- NO HEALTH TOPIC --
- Childhood Weight Control Program
- NEW CLINICAL TRIAL
- Price changes and food purchases in adult grocery shoppers
- Stress and Choice Study
- Study of Ingestive Behavior in Siblings (SIBS) study
- Anxiety Disorders and PTSD
- Cancer
- Preliminary Clinical Application of 11C-Choline Positron Emission Tomography in Prostate Cancer Patients
- TUMOR HYPOXIA IMAGING WITH CU-62 ATSM: A PILOT STUDY
- Child and Adolescent Mental Disorders
- A Comparison of Two Parenting Programs for Mothers and Fathers of Children with ADHD
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety And Tolerability Of Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder (B2061032)
- Rapid Pediatric Psychiatric Consultation -Quality Assurance Protocol
- Children's Health
- Effects of rewards on attention, memory, and inhibiting in children with and without ADHD
- Adaptive Interventions for Children with ADHD
- A Multicenter, Prospective, Long-Term, Observational Registry of Pediatric Patients with Inflammatory Bowel Disease.
- A Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children with Crohn's Disease.
- Rapid Pediatric Psychiatric Consultation -Quality Assurance Protocol
- Cholesterol
- Depression
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety And Tolerability Of Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder (B2061032)
- Prevalence of Bipolar Disorder in Family Practice
- Diabetes
- Inflammation In obesity: Modulation by Weight Loss
- Effect of Androgel on Atherogenesis, Inflammation, Cardiovascular Risk Factors And Adiposity in Type 2 Diabetic Males with Hypogonadotrophic Hypogonadism.: a Prospective, Randomized and Controlled-Study.
- Effect of AndroGel on Inflammatory Mediators and Oxidative Stress in Type 2 Diabetic Males with Hypogonadism
- EFFECT OF JANUVIA (SITAGLIPTIN) ON OXIDATIVE STRESS IN OBESE TYPE 2 DIABETIC SUBJECTS
- NAVIGATOR: A multinational, randomized, double-blind, placebo-controlled, forced titration, 2x2 factorial design study of the efficacy and safety of long term administration of nateglinide and valsartan in the prevention of diabetes and cardiovascular outcomes in subjects with impaired glucose tolerance (IGT)
- Study of Insulin for Anti-Inflammatory Action
- The Suppression of Toll like Receptors (TLR) by Insulin
- Vascular Benefits of Adding Carvedilol CR to Type 2 Diabetic Patients on ACEi: Effects on Oxidative Stress and Inflammation.
- Digestive System
- SmartPill Colonic Transit Time Validation Study in Patients With Chronic Constipation
- TUMOR HYPOXIA IMAGING WITH CU-62 ATSM: A PILOT STUDY
- A Multicenter, Prospective, Long-Term, Observational Registry of Pediatric Patients with Inflammatory Bowel Disease.
- A Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children with Crohn's Disease.
- Self Administered Treatment for irritable bowel syndrome
- SmartPill Colonic Transit Time Validation Study in Patients With Chronic Constipation
- Heart
- AIM-HIGH "ATHEROTHROMBOSIS INTERVENTION IN METABOLIC SYNDROME with low HDL/HIGH TRIGLYCERIDE and IMPACT ON GLOBAL HEALTH OUTCOMES
- Evaluate the effects of RO4607381 on cardiovascular (CV) risk in stable CHD patients, with a documented recent Acute Coronary Syndrome (M&M)
- NAVIGATOR: A multinational, randomized, double-blind, placebo-controlled, forced titration, 2x2 factorial design study of the efficacy and safety of long term administration of nateglinide and valsartan in the prevention of diabetes and cardiovascular outcomes in subjects with impaired glucose tolerance (IGT)
- Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT)
- Warfarin vs. Aspirin in Reduced Cardiac Ejection Fraction
- Immune System
- Lung
- TUMOR HYPOXIA IMAGING WITH CU-62 ATSM: A PILOT STUDY
- An Open-Label, Multi-Center Study Employing a Targeted 6-MWT Distance Threshold Approach to Guide Bosentan-Based Therapy and to Assess the Utility of MRI on Cardiac Remodeling (COMPASS 3)
- Memory and Aging
- Men's Health
- Preliminary Clinical Application of 11C-Choline Positron Emission Tomography in Prostate Cancer Patients
- Self Administered Treatment for irritable bowel syndrome
- Mental Health
- Effects of rewards on attention, memory, and inhibiting in children with and without ADHD
- A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of Lurasidone for the Maintenance Treatment of Subjects with Schizophrenia (D1050238)
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety And Tolerability Of Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder (B2061032)
- A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms (Study 165)
- A Phase III, multi-center, randomized, 24 week, double-blind, parallel-group, placebo-controlled study to evaluate efficacy and safety of RO4917838 in stable patients with persistent, predominant negative symptoms of schizophrenia treated with antipsychotics followed by a 28 week, double-blind treatment period (WN25308)
- ASPIRE (Aripiprazole Intramuscular Depot Program in Schizophrenia) long-acting injectable formulation of Abilify (FDA, IRB approved Otsuka Study 31-07-247)
- ASPIRE US (Aripiprazole Intramuscular Depot Program in Schizophrenia)
- Olanzapine-Associated Weight Gain in Healthy Males
- Phase III, multi-center, randomized, 12-week, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of RO4917838 in patients with sub-optimally controlled symptoms of schizophrenia treated with antipsychotics followed by a 40-week double-blind, parallel-group, placebo-controlled treatment period (WN25305)
- Prevalence of Bipolar Disorder in Family Practice
- Rapid Pediatric Psychiatric Consultation -Quality Assurance Protocol
- Metabolic Disorders
- Metabolism
- Mood disorders
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety And Tolerability Of Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder (B2061032)
- Prevalence of Bipolar Disorder in Family Practice
- Pain
- Schizophrenia and related conditions
- A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of Lurasidone for the Maintenance Treatment of Subjects with Schizophrenia (D1050238)
- A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms (Study 165)
- A Phase III, multi-center, randomized, 24 week, double-blind, parallel-group, placebo-controlled study to evaluate efficacy and safety of RO4917838 in stable patients with persistent, predominant negative symptoms of schizophrenia treated with antipsychotics followed by a 28 week, double-blind treatment period (WN25308)
- ASPIRE (Aripiprazole Intramuscular Depot Program in Schizophrenia) long-acting injectable formulation of Abilify (FDA, IRB approved Otsuka Study 31-07-247)
- Phase III, multi-center, randomized, 12-week, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of RO4917838 in patients with sub-optimally controlled symptoms of schizophrenia treated with antipsychotics followed by a 40-week double-blind, parallel-group, placebo-controlled treatment period (WN25305)
- Prevalence of Bipolar Disorder in Family Practice
- Urinary Tract
- Preliminary Clinical Application of 11C-Choline Positron Emission Tomography in Prostate Cancer Patients
- TUMOR HYPOXIA IMAGING WITH CU-62 ATSM: A PILOT STUDY
- Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR)
- Weight Control
- Women's Health
Search for Clinical Trials
> View by Topic
> View by Department
Contact Us
For more information about clinical trials please contact the office of Research and Biomedical Education
Phone: 716-829-3398
Fax: 716-829-2437